voxmdtemplate

About voxmdtemplate

This author has not yet filled in any details.
So far voxmdtemplate has created 6 blog entries.

Vascular Dynamics Names Prof. Martin Rothman Chief Medical Officer

World-Renowned Expert Assumes New Leadership Role at VDI Jan 23, 2019 MOUNTAIN VIEW, CALIF - (January 23, 2019) - Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on innovative, minimally invasive device-based solutions for cardiovascular conditions, has announced the appointment of Martin T. Rothman FRCP, FACC, FESC as Chief Medical Officer, effective [...]

2019-02-18T23:15:38+00:00January 23rd, 2019|

Vascular Dynamics Announces Initial Enrollment in Rigorously Designed Hypertension Trial

CALM-2 Trial Studies Effectiveness of Unique Endovascular Baroreceptor Amplification Device Sept 4, 2018 MOUNTAIN VIEW, Calif.– (September 4, 2018) – Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on innovative, minimally invasive device-based solutions for cardiovascular conditions, today announced enrollment of the first patients in an FDA-approved best-in-class pivotal clinical trial. The [...]

2019-02-19T17:19:54+00:00September 4th, 2018|

Vascular Dynamics Appoints Ed Roschak CEO

Dec 4, 2017 MOUNTAIN VIEW, Calif.– (December 4, 2017) –Vascular Dynamics, Inc. (VDI), a privately held medical device company which has developed an innovative treatment system for the treatment of hypertension, today announced the appointment of Mr. Ed Roschak as its president and chief executive officer. "We are fortunate that Ed has decided to [...]

2019-02-19T17:22:47+00:00December 4th, 2017|

Vascular Dynamics Interim Data on MobiusHD Presented at TCT Conference Shows Significant Reductions in Ambulatory Systolic Blood Pressure At Six Months

Oct 30, 2017 Company Has Initiated Pivotal Trial for the MobiusHD in the US and EU MOUNTAIN VIEW, Calif.– (October 30, 2017) –Vascular Dynamics, Inc., a privately held medical device company developing novel solutions for the treatment of hypertension, will present updated interim results of the company's first-in-human trial of its MobiusHD® implant today [...]

2019-02-19T17:27:07+00:00October 30th, 2017|

Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension

Sep 15, 2017 MOUNTAIN VIEW, Calif.– (August 13, 2017) –Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces that the United States Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) application to initiate its pivotal trial for its [...]

2019-02-19T17:30:31+00:00September 15th, 2017|

Data Published in The Lancet Shows Positive Results at Primary Endpoint in the Treatment of Resistant Hypertension with MobiusHD Device

Sep 1, 2017 Publication Follows Positive Interim Results in US and EU Patients Presented at the European Society of Cardiology Conference MOUNTAIN VIEW, Calif.– (September 1, 2017) –Vascular Dynamics, Inc. (VDI), a privately held medical device company developing novel solutions for the treatment of hypertension, today announced European results of the company's first-in-human trial [...]

2019-02-19T17:32:16+00:00September 1st, 2017|
Go to Top